Autotransporter-based antigen display in bacterial ghosts

Applied and Environmental Microbiology

Volumn 81, Issue 2, 2015, Pages 726-735

  Hjelm, Anna ^a   Söderström, Bill ^a,e   Vikström, David ^b   Jong, Wouter S P ^c,d   Luirink, Joen ^c,d   de Gier, Jan Willem ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b Xbrane Bioscience AB   (Sweden)

^c Abera Bioscience AB   (Sweden)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY GRADUATE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; COST EFFECTIVENESS; ELECTRON MICROSCOPES; ELECTRON MICROSCOPY; ESCHERICHIA COLI; FLUORESCENCE; FLUORESCENCE MICROSCOPY; PROTEINS; SALMONELLA; VACCINES;

ANTIGEN DELIVERY; BACTERIAL GHOSTS; CELLULAR MARKERS; EFFICIENT SURFACE; GRAM-NEGATIVE BACTERIA; LYSIS EFFICIENCIES; MYCOBACTERIUM TUBERCULOSIS; SURFACE DISPLAYS;

ANTIGENS;

ANTIGEN; BACTERIUM; CELLS AND CELL COMPONENTS; COST-BENEFIT ANALYSIS; IMMUNE SYSTEM; IMMUNOASSAY; LYSIS; PROTEIN; VACCINE;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MYCOBACTERIUM TUBERCULOSIS; NEGIBACTERIA; SALMONELLA;

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIAL VACCINE; E PROTEIN, BACTERIOPHAGE X174; ESAT-6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; HEMOGLOBIN PROTEASE HBP; INACTIVATED VACCINE; MEMBRANE PROTEIN; PROTEINASE; VIRUS PROTEIN;

CELL SURFACE DISPLAY; ESCHERICHIA COLI; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; SALMONELLA;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; CELL SURFACE DISPLAY TECHNIQUES; ENDOPEPTIDASES; ESCHERICHIA COLI; MEMBRANE PROTEINS; SALMONELLA; VACCINES, INACTIVATED; VIRAL PROTEINS;

EID: 84920747023     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.02733-14     Document Type: Article

References (39)

1. Langemann T, Koller VJ, Muhammad A, Kudela P, Mayr UB, Lubitz W. 2010. The Bacterial Ghost platform system: production and applications. Bioeng Bugs 1:326-336. http://dx.doi.org/10.4161/bbug.1.5.12540.
2. Kudela P, Koller VJ, Lubitz W. 2010. Bacterial ghosts (BGs)-advanced antigen and drug delivery system. Vaccine 28:5760-5767. http://dx.doi.org/10.1016/j.vaccine.2010.06.087.
3. Riedmann EM, Kyd JM, Cripps AW, Lubitz W. 2007. Bacterial ghosts as adjuvant particles. Expert Rev Vaccines 6:241-253. http://dx.doi.org/10 .1586/14760584.6.2.241.
4. Young R. 1992. Bacteriophage lysis: mechanism and regulation. Microbiol Rev 56:430-481.
5. Blasi U, Linke RP, Lubitz W. 1989. Evidence for membrane-bound oligomerization of bacteriophage phi X174 lysis protein-E. J Biol Chem 264:4552-4558.
6. Tanaka S, Clemons WM, Jr. 2012. Minimal requirements for inhibition of MraY by lysis protein E from bacteriophage PhiX174. Mol Microbiol 85:975-985. http://dx.doi.org/10.1111/j.1365-2958.2012.08153.x.
7. Zheng Y, Struck DK, Young R. 2009. Purification and functional characterization of phiX174 lysis protein E. Biochemistry 48:4999-5006. http://dx.doi.org/10.1021/bi900469g.
8. Bernhardt TG, Roof WD, Young R. 2000. Genetic evidence that the bacteriophage phi X174 lysis protein inhibits cell wall synthesis. Proc Natl Acad Sci U S A 97:4297-4302. http://dx.doi.org/10.1073/pnas.97.8.4297.
9. Witte A, Wanner G, Blasi U, Halfmann G, Szostak M, Lubitz W. 1990. Endogenous transmembrane tunnel formation mediated by phi X174 lysis protein E. J Bacteriol 172:4109-4114.
10. Witte A, Schrot G, Schon P, Lubitz W. 1997. Proline 21, a residue within the alpha-helical domain of phiX174 lysis protein E, is required for its function in Escherichia coli. Mol Microbiol 26:337-346. http://dx.doi.org/10.1046/j.1365-2958.1997.5781941.x.
11. Schon P, Schrot G, Wanner G, Lubitz W, Witte A. 1995. Two-stage model for integration of the lysis protein E of phi X174 into the cell envelope of Escherichia coli. FEMS Microbiol Rev 17:207-212.
12. Choi SH, Nam YK, Kim KH. 2010. Novel expression system for combined vaccine production in Edwardsiella tarda ghost and cadaver cells. Mol Biotechnol 46:127-133. http://dx.doi.org/10.1007/s12033-010 -9277-2.
13. Jechlinger W, Haller C, Resch S, Hofmann A, Szostak MP, Lubitz W. 2005. Comparative immunogenicity of the hepatitis B virus core 149 antigen displayed on the inner and outer membrane of bacterial ghosts. Vaccine 23:3609-3617. http://dx.doi.org/10.1016/j.vaccine.2004.11.078.
14. Hess J, Gentschev I, Miko D, Welzel M, Ladel C, Goebel W, Kaufmann SH. 1996. Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc Natl Acad Sci U S A 93:1458-1463. http://dx.doi.org/10.1073/pnas .93.4.1458.
15. Kang HY, Curtiss R, III. 2003. Immune responses dependent on antigen location in recombinant attenuated Salmonella typhimurium vaccines following oral immunization. FEMS Immunol Med Microbiol 37:99-104. http://dx.doi.org/10.1016/S0928-8244(03)00063-4.
16. Muralinath M, Kuehn MJ, Roland KL, Curtiss R, III. 2011. Immunization with Salmonella enterica serovar Typhimurium-derived outer membrane vesicles delivering the pneumococcal protein PspA confers protection against challenge with Streptococcus pneumoniae. Infect Immun 79: 887-894. http://dx.doi.org/10.1128/IAI.00950-10.
17. van Ulsen P, Rahman SU, Jong WS, Daleke-Schermerhorn MH, Luirink J. 2014. Type V secretion: from biogenesis to biotechnology. Biochim Biophys Acta 1843:1592-1611. http://dx.doi.org/10.1016/j.bbamcr.2013 .11.006.
18. Jong WS, Sauri A, Luirink J. 2010. Extracellular production of recombinant proteins using bacterial autotransporters. Curr Opin Biotechnol 21:646-652. http://dx.doi.org/10.1016/j.copbio.2010.07.009.
19. Jong WS, Soprova Z, de Punder K, ten Hagen-Jongman CM, Wagner S, Wickstrom D, de Gier JW, Andersen P, van der Wel NN, Luirink J. 2012. A structurally informed autotransporter platform for efficient heterologous protein secretion and display. Microb Cell Fact 11:85. http://dx.doi.org/10.1186/1475-2859-11-85.
20. Sorensen AL, Nagai S, Houen G, Andersen P, Andersen AB. 1995. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun 63:1710-1717.
21. Jong WS, ten Hagen-Jongman CM, den Blaauwen T, Slotboom DJ, Tame JR, Wickstrom D, de Gier JW, Otto BR, Luirink J. 2007. Limited tolerance towards folded elements during secretion of the autotransporter Hbp. Mol Microbiol 63:1524-1536. http://dx.doi.org/10.1111/j.1365 -2958.2007.05605.x.
22. Detmer A, Glenting J. 2006. Live bacterial vaccines-a review and identification of potential hazards. Microb Cell Fact 5:23. http://dx.doi.org/10 .1186/1475-2859-5-23.
23. Casadaban MJ. 1976. Transposition and fusion of the lac genes to selected promoters in Escherichia coli using bacteriophage lambda and Mu. J Mol Biol 104:541-555. http://dx.doi.org/10.1016/0022-2836(76)90119-4.
24. Weiss DS, Chen JC, Ghigo JM, Boyd D, Beckwith J. 1999. Localization of FtsI (PBP3) to the septal ring requires its membrane anchor, the Z ring, FtsA, FtsQ, and FtsL. J Bacteriol 181:508-520.
25. Hoiseth SK, Stocker BA. 1981. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291:238- 239. http://dx.doi.org/10.1038/291238a0.
26. Giacalone MJ, Gentile AM, Lovitt BT, Berkley NL, Gunderson CW, Surber MW. 2006. Toxic protein expression in Escherichia coli using a rhamnose-based tightly regulated and tunable promoter system. Biotechniques 40:355-364. http://dx.doi.org/10.2144/000112112.
27. Skerra A. 1994. Use of the tetracycline promoter for the tightly regulated production of a murine antibody fragment in Escherichia coli. Gene 151: 131-135. http://dx.doi.org/10.1016/0378-1119(94)90643-2.
28. Peubez I, Chaudet N, Mignon C, Hild G, Husson S, Courtois V, De Luca K, Speck D, Sodoyer R. 2010. Antibiotic-free selection in E. coli: new considerations for optimal design and improved production. Microb Cell Fact 9:65. http://dx.doi.org/10.1186/1475-2859-9-65.
29. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97:6640-6645. http://dx.doi.org/10.1073/pnas.120163297.
30. Froderberg L, Rohl T, van Wijk KJ, de Gier JW. 2001. Complementation of bacterial SecE by a chloroplastic homologue. FEBS Lett 498:52-56. http://dx.doi.org/10.1016/S0014-5793(01)02494-2.
31. Lubitz W. June 2011. US patent 7,968,323 B2. http://www.google.com /patents/US7968323.pdf.
32. Wagner S, Baars L, Ytterberg AJ, Klussmeier A, Wagner CS, Nord O, Nygren PA, van Wijk KJ, de Gier JW. 2007. Consequences of membrane protein overexpression in Escherichia coli. Mol Cell Proteomics 6:1527- 1550. http://dx.doi.org/10.1074/mcp.M600431-MCP200.
33. Haidinger W, Szostak MP, Beisker W, Lubitz W. 2001. Green fluorescent protein (GFP)-dependent separation of bacterial ghosts from intact cells by FACS. Cytometry 44:106-112. http://dx.doi.org/10.1002/1097 -0320(20010601)44:2 106::AID-CYTO1088 3.0.CO;2-5.
34. Haidinger W, Szostak MP, Jechlinger W, Lubitz W. 2003. Online monitoring of Escherichia coli ghost production. Appl Environ Microbiol 69: 468-474. http://dx.doi.org/10.1128/AEM.69.1.468-474.2003.
35. Fishov I, Woldringh CL. 1999. Visualization of membrane domains in Escherichia coli. Mol Microbiol 32:1166-1172. http://dx.doi.org/10.1046 /j.1365-2958.1999.01425.x.
36. Mayr UB, Haller C, Haidinger W, Atrasheuskaya A, Bukin E, Lubitz W, Ignatyev G. 2005. Bacterial ghosts as an oral vaccine: a single dose of Escherichia coli O157:H7 bacterial ghosts protects mice against lethal challenge. Infect Immun 73:4810-4817. http://dx.doi.org/10.1128/IAI.73.8 .4810-4817.2005.
37. Perrin P, Morgeaux S. 1995. Inactivation of DNA by beta-propiolactone. Biologicals 23:207-211. http://dx.doi.org/10.1006/biol.1995.0034.
38. Galan JE, Nakayama K, Curtiss R, III. 1990. Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains. Gene 94:29-35. http://dx.doi.org/10.1016/0378-1119(90)90464-3.
39. McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, Hou S, Layman D, Leonard S, Nguyen C, Scott K, Holmes A, Grewal N, Mulvaney E, Ryan E, Sun H, Florea L, Miller W, Stoneking T, Nhan M, Waterston R, Wilson RK. 2001. Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 413:852-856. http://dx.doi.org/10.1038/35101614.